Procalcitonin (PCT) in patients with abdominal sepsis
To assess the accuracy of procalcitonin as a measure of severity in patients with septic abdominal illnesses and the sepsis syndrome, to compare measurements with those of other inflammatory mediators, and to predict outcome.
We carried out a prospective clinical study from 246 patients with infective or septic episodes confirmed at laparotomy and 66 patients undergoing elective operations who acted as controls. Specimens of blood for measurement of cytokine concentrations determination were obtained daily from septic patients. In the control group specimens were obtained before operation, at the end of operation, and on each of the following days until normal recovery (day 10). Every two weeks up to 3 months for patients with metastases, who were being followed up.
Compared with other cytokines such as tumor necrosis factor αa and interleukin 6 procalcitonin was closely related to the development of infective and septic complications. 59 of 246 patients (24%) with sepsis died. Procalcitonin concentrations preoperatively [median 2.05 compared with 4.2 ng/ml (p=0.08)] (Mann-Whitney U-test) did not differ, but those on the days 1,4 and at the end differed significantly [day 1∶4.9 compared with 13.8 ng/ml (p<0.01); day 4∶4.8 compared with 13.0 ng/ml (p<0.01) and 0.4 compared with 13.25 ng/ml (p<0.01) at the end of the study]. In the control group only 7 (1.6%) of all blood samples, were detected outside the normal range (up to 0.8 ng/ml).
Procalcitonin is a new indicator of infection and sepsis. TNF and IL-6 concentrations always rise after major operations and fall in the absence of infection, indicating operative trauma. Procalcitonin is sensitive in detecting infective complications. Under routine conditions the procalcitonin concentrations seems to be valid, reproducible and detectable.
Key wordsPeritonitis Sepsis Septic courses Diagnosis Cytokines Procalcitonin
- 2.Reith HB, Dittrich H, Haarmann W, Smektala R, Dohle J, Kozuschek W (1996) Adjuvante Therapie der Peritonitis und ihrer septischer Verlaufsformen mit Taurolidin—eine prospektive randomisierte Untersuchung. Chir. Gastroenterologie 12, p 358Google Scholar
- 9.Goris RJA, Boekhorst TPA, Nuytinck JKS (1985) Multiple organ failure. Arch Surg 118, p 1109Google Scholar
- 11.Beier W (1994) Procalcitonin (ProCt)—ein innovativer Inflammationsparameter mit prognostischen Eigenschaften (editorial). Anästh Intensivmed 36: 18Google Scholar
- 12.Huttemeier PC, Ritter EF, Benveniste H (1993) Calcitonin gene-related peptide mediates hypotension and tachycardia in endotoxin rats. Am J Physiol 265, p 4767Google Scholar
- 15.Brunkhorst FM, Forycki ZF, Beier W, Wagner J (1993) Discrimination of infectious and non-infectious etiologies of the adult respiratory distress syndrome (ARDS) with procalcitonin immunoreactivity. Clin Intensive Care 3, p 12Google Scholar